Weiner LM - Search Results

1

Weiner LM, Adams GP. Weiner LM, et al. Oncogene. 2000 Dec 11;19(53):6144-51. doi: 10.1038/sj.onc.1204000. Oncogene. 2000. PMID: 11156528 Review.

2

Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.

Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM. Garcia de Palazzo I, et al. Among authors: weiner lm. Cancer Res. 1992 Oct 15;52(20):5713-9. Cancer Res. 1992. PMID: 1394194

3

Applications of gamma-interferon in cancer therapy.

Weiner LM. Weiner LM. Mol Biother. 1991 Dec;3(4):186-91. Mol Biother. 1991. PMID: 1768369 Review.

4

Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.

de Palazzo IG, Gercel-Taylor C, Kitson J, Weiner LM. de Palazzo IG, et al. Among authors: weiner lm. Cancer Res. 1990 Nov 15;50(22):7123-8. Cancer Res. 1990. PMID: 2146012

5

Effector characteristics of the IgG3 murine monoclonal antibody 113F1.

Weiner LM, Zarou CM, O'Brien J, Ring D. Weiner LM, et al. J Biol Response Mod. 1989 Jun;8(3):227-37. J Biol Response Mod. 1989. PMID: 2787391

6

Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.

Weiner LM, Steplewski Z, Koprowski H, Litwin S, Comis RL. Weiner LM, et al. Cancer Res. 1988 Feb 15;48(4):1042-6. Cancer Res. 1988. PMID: 3123051

7

Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.

Weiner LM, Moldofsky PJ, Gatenby RA, O'Dwyer J, O'Brien J, Litwin S, Comis RL. Weiner LM, et al. Cancer Res. 1988 May 1;48(9):2568-73. Cancer Res. 1988. PMID: 3128400

8

Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.

McCartney JE, Tai MS, Hudziak RM, Adams GP, Weiner LM, Jin D, Stafford WF 3rd, Liu S, Bookman MA, Laminet AA, et al. McCartney JE, et al. Among authors: weiner lm. Protein Eng. 1995 Mar;8(3):301-14. doi: 10.1093/protein/8.3.301. Protein Eng. 1995. PMID: 7479692

9

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Weiner LM, Clark JI, Davey M, Li WS, Garcia de Palazzo I, Ring DB, Alpaugh RK. Weiner LM, et al. Cancer Res. 1995 Oct 15;55(20):4586-93. Cancer Res. 1995. PMID: 7553634 Clinical Trial.

10

Intracellular single-chain Fv antibodies--a knockout punch for neoplastic cells?

Adams GP, Weiner LM. Adams GP, et al. Among authors: weiner lm. Gynecol Oncol. 1995 Oct;59(1):6-7. doi: 10.1006/gyno.1995.1259. Gynecol Oncol. 1995. PMID: 7557617 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters